UniProt ID | C1QA_HUMAN | |
---|---|---|
UniProt AC | P02745 | |
Protein Name | Complement C1q subcomponent subunit A | |
Gene Name | C1QA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 245 | |
Subcellular Localization | Secreted. | |
Protein Description | C1q associates with the proenzymes C1r and C1s to yield C1, the first component of the serum complement system. The collagen-like regions of C1q interact with the Ca(2+)-dependent C1r(2)C1s(2) proenzyme complex, and efficient activation of C1 takes place on interaction of the globular heads of C1q with the Fc regions of IgG or IgM antibody present in immune complexes.. | |
Protein Sequence | MEGPRGWLVLCVLAISLASMVTEDLCRAPDGKKGEAGRPGRRGRPGLKGEQGEPGAPGIRTGIQGLKGDQGEPGPSGNPGKVGYPGPSGPLGARGIPGIKGTKGSPGNIKDQPRPAFSAIRRNPPMGGNVVIFDTVITNQEEPYQNHSGRFVCTVPGYYYFTFQVLSQWEICLSIVSSSRGQVRRSLGFCDTTNKGLFQVVSGGMVLQLQQGDQVWVEKDPKKGHIYQGSEADSVFSGFLIFPSA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
33 | Hydroxylation | CRAPDGKKGEAGRPG HCCCCCCCCCCCCCC | 68.46 | 486087 | |
33 | O-linked_Glycosylation | CRAPDGKKGEAGRPG HCCCCCCCCCCCCCC | 68.46 | 486087 | |
39 | Hydroxylation | KKGEAGRPGRRGRPG CCCCCCCCCCCCCCC | 39.46 | 486087 | |
45 | Hydroxylation | RPGRRGRPGLKGEQG CCCCCCCCCCCCCCC | 56.12 | 486087 | |
48 | Hydroxylation | RRGRPGLKGEQGEPG CCCCCCCCCCCCCCC | 67.33 | 486087 | |
48 | O-linked_Glycosylation | RRGRPGLKGEQGEPG CCCCCCCCCCCCCCC | 67.33 | 486087 | |
54 | Hydroxylation | LKGEQGEPGAPGIRT CCCCCCCCCCCCHHH | 51.58 | 486087 | |
57 | Hydroxylation | EQGEPGAPGIRTGIQ CCCCCCCCCHHHCCC | 44.66 | 486087 | |
67 | Hydroxylation | RTGIQGLKGDQGEPG HHCCCCCCCCCCCCC | 68.23 | 486087 | |
67 | O-linked_Glycosylation | RTGIQGLKGDQGEPG HHCCCCCCCCCCCCC | 68.23 | 486087 | |
73 | Hydroxylation | LKGDQGEPGPSGNPG CCCCCCCCCCCCCCC | 67.81 | 486087 | |
79 | Hydroxylation | EPGPSGNPGKVGYPG CCCCCCCCCCCCCCC | 47.73 | 486087 | |
85 | Hydroxylation | NPGKVGYPGPSGPLG CCCCCCCCCCCCCCC | 42.14 | 486087 | |
100 | Hydroxylation | ARGIPGIKGTKGSPG CCCCCCCCCCCCCCC | 67.45 | 486087 | |
100 | O-linked_Glycosylation | ARGIPGIKGTKGSPG CCCCCCCCCCCCCCC | 67.45 | 486087 | |
103 | Hydroxylation | IPGIKGTKGSPGNIK CCCCCCCCCCCCCCC | 67.09 | - | |
146 | N-linked_Glycosylation | NQEEPYQNHSGRFVC CCCCCCCCCCCCEEE | 26.00 | 17623646 | |
146 | N-linked_Glycosylation | NQEEPYQNHSGRFVC CCCCCCCCCCCCEEE | 26.00 | 16335952 | |
174 | Phosphorylation | SQWEICLSIVSSSRG CCHHHHHHHHHCCCC | 19.28 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of C1QA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of C1QA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of C1QA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PGS2_HUMAN | DCN | physical | 1431141 | |
C1S_HUMAN | C1S | physical | 10878362 | |
C1R_HUMAN | C1R | physical | 10878362 | |
FINC_HUMAN | FN1 | physical | 6981115 | |
UBQL2_HUMAN | UBQLN2 | physical | 21988832 | |
SGTA_HUMAN | SGTA | physical | 21988832 | |
PIAS2_HUMAN | PIAS2 | physical | 21988832 | |
UBQL1_HUMAN | UBQLN1 | physical | 21988832 | |
GNA1_HUMAN | GNPNAT1 | physical | 21988832 | |
RAC1_HUMAN | RAC1 | physical | 25301945 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
613652 | Complement component C1q deficiency (C1QD) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-146, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-146, AND MASSSPECTROMETRY. |